Table 1.
A detailed description of patient's blood morphology throughout the treatment process and additional key symptoms observed in the process
| Days of hospitalization | ||||||
|---|---|---|---|---|---|---|
| 7 | 9 | 10 | 11 | 13 | 14 | |
| Parameter value in PB | ||||||
| Leukocytes [103 /μl] | 9.77 | 7.47 | 6.03 | 9.38 | 5.9 | 6.27 |
| Neutrophils [%] | 82.7 | 62.1 | 84.1 | 79 | 57.4 | 62.4 |
| Eosinophils [%] | 1.6 | 12 | 2 | 1.5 | 13.4 | 8.8 |
| Basophils [%] | 0.2 | 0.8 | 0 | 0.2 | 1 | 0.6 |
| Lymphocytes [%] | 12 | 15.3 | 9.1 | 15.4 | 21.5 | 21.5 |
| Monocytes [%] | 3.4 | 9.8 | 4.8 | 3.9 | 9.7 | 6.7 |
| Erythrocytes [106 /μl] | 4 | 3.5 | 3 | 3.2 | 3.5 | 3.6 |
| Hemoglobin [g/dl] | 11.2 | 10.4 | 8.5 | 9.3 | 10.1 | 10.3 |
| Hematocrit [%] | 34.3 | 31.4 | 25.7 | 27.3 | 30.1 | 29.8 |
| MCV [10−15 /μl] | 86.4 | 89 | 85.7 | 84.5 | 87 | 83.5 |
| MCH [pg/cell] | 28.2 | 29.5 | 28.3 | 28.8 | 29.2 | 28.9 |
| MCHC [g/dl] | 32.7 | 33.1 | 33.1 | 34.1 | 33.6 | 34.6 |
| RDW-CV [%] | 12.9 | 14.9 | 13 | 13 | 14.1 | 13.8 |
| PLT [10−15 /μl] | 310 | 365 | 181 | 228 | 305 | 322 |
| MPV [10−15 /μl] | 11 | 11 | 12.7 | 12.9 | 10.6 | 10.9 |
| AspAT [U/l] | 87 | 64 | ||||
| AlAT [U/l] | 109 | 97 | ||||
| CRP [mg/l] | 89.5 | 8.13 | 73.2 | 131 | 19.1 | 21.4 |
| CK [U/l] | 1144 | |||||
[i] PB – Peripherical blood
[ii] On Day 7 of hospitalisation, patient presented with an upper lip swelling and maculopapular rash. On Day 9 of hospitalisation, the rash and the swelling have decreased. On Day 10, after olanzapine administration was increased, the patient presented with a 40°C body temperature and eosinophilia visible in the blood smear. On Day 13, patient was diagnosed with bacterial infection of Staphylococcus aureus and Acinetobacter baumani. The antibiotic therapy as well as antihistamine treatment were modified. Since then, patient's state was gradually improving until discharge from the ICU on Day 23.